Results 91 to 100 of about 1,572 (142)

Venetoclax-proteasome inhibitor-dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Blood Adv
Khalife-Hachem S, Pages A, Akoury E, Bonnet S, Birsen R, Busquet C, Contejean A, Danu A, de Botton S, de Charette M, Dumas PY, Jaccard A, Marfaing-Koka A, Willekens C, Deconinck E, Ghez D.   +15 more
europepmc   +1 more source

Cutaneous Manifestation of a Rare Haematological Malignancy: A Case Report of the Presentation, Diagnosis, and Management of Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

Cureus
Hassan SL, Chatha DE.
europepmc   +1 more source

A Case of Cutaneous Blastic Plasmacytoid Dendritic Cell Neoplasm on the Chest. [PDF]

Cureus
Tokioka R, Saito-Sasaki N, Sawada Y.
europepmc   +1 more source

Venetoclax and hypomethylating agents versus tagraxofusp in older patients with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Ann Hematol
Lee BJ.
europepmc   +1 more source

Immunotherapies Targeting CD123 and CD303: A New Frontier in Treating Blastic Plasmacytoid Dendritic Cell Neoplasm. [PDF]

Int J Mol Sci
Galati D, Zanotta S, Florio F, Mele S, De Filippi R, Pinto A.   +5 more
europepmc   +1 more source

Single cell sequencing deciphering the heterogeneous landscape of blastic plasmacytoid dendritic cell neoplasm with novel MYB-ZFAT fusion gene. [PDF]

Cancer Cell Int
Li R, Kuang W, Yang H, Zhang B, Zhao K, Fang W, Cheng Z, Fu X, Peng H.   +8 more
europepmc   +1 more source

Blastic plasmacytoid dendritic cell neoplasm: Two case reports. [PDF]

World J Clin Oncol
Ma YQ, Sun Z, Li YM, Xu H.
europepmc   +1 more source

Blastic Plasmacytoid Dendritic Cell Neoplasm: A Case Report of a Rare and Aggressive Hematologic Malignancy. [PDF]

Cureus
Saha K, Thoram GSK, Roychoudhury S.
europepmc   +1 more source

Tagraxofusp maintenance post-hematopoietic stem cell transplantation provides long-term survival and manageable safety for a patient with blastic plasmacytoid dendritic cell neoplasm. [PDF]

Leuk Res Rep
Bashir Q, Konopleva M, Abueg G, Ramdial J, Hosing C, Srour SA, Alousi A, Popat UR, Nieto Y, Alatrash G, Champlin RE, Shpall EJ, Qazilbash M, Pemmaraju N.   +13 more
europepmc   +1 more source